Truist Securities Maintains Buy on HCA Healthcare, Raises Price Target to $310
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $290 to $310.
JP Morgan Downgrades HCA Healthcare to Neutral, Announces $270 Price Target
JP Morgan analyst Lisa Gill downgrades HCA Healthcare (NYSE:HCA) from Overweight to Neutral and announces $270 price target.
Analyst Ratings For HCA Healthcare
Analysts have provided the following ratings for HCA Healthcare (NYSE:HCA) within the last quarter:
Here’s How Much You Would Have Made Owning HCA Healthcare Stock In The Last 5 Years
HCA Healthcare (NYSE:HCA) has outperformed the market over the past 5 years by 10.82% on an annualized basis.
CFO Of Hca Healthcare Sold $7.5M In Stock
Bill Rutherford, CFO And Evp at Hca Healthcare (NYSE:HCA), made a large insider sell on November 4, according to a new SEC filing.
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Notable Hca Healthcare Insider Trades $2.6M In Company Stock
Kathleen Whalen, SVP And Chief Ethics Officer at Hca Healthcare (NYSE:HCA), made a large buy and sell of company shares on November 4, according to a new SEC filing.
Notable Hca Healthcare Insider Trades $39M In Company Stock
Samuel Hazen, CEO at Hca Healthcare (NYSE:HCA), made a large buy and sell of company shares on November 2, according to a new SEC filing.
Oscar Health Reports Partnership With HCA Healthcare Across 5 Texas Markets
Oscar Announces Partnerships with HCA Healthcare to offer seamlessly connected health insurance and care across El Paso, San Antonio, Austin, Houston, and Dallas-Fort Worth, Texas.
Oscar Individual and Family plans